Merck & Company, Inc. News Headlines

MRK 
$56.74
*  
1.34
2.31%
Get MRK Alerts
*Delayed - data as of Jul. 31, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Stock Buyback Announcements Slow To $2.3 Billion Daily In Third Quarter
9/20/2013 1:57:00 PM - Seeking Alpha

Eli Lilly And Merck: A Pipeline Of Success?
9/16/2013 3:57:00 PM - Seeking Alpha

Dividend Growth Investing: A Prospective Study
9/16/2013 2:32:00 PM - Seeking Alpha

Niraparib And Rolapitant Will Take Tesaro To New Heights
9/13/2013 3:21:00 PM - Seeking Alpha

Is There Much Hope For Merck In Alzheimer's Drug Clinical Trials?
9/11/2013 6:08:00 PM - Seeking Alpha

China's Diabetes Market Could Become A Big Focus For Pharma Companies
9/11/2013 11:15:00 AM - Seeking Alpha

Dow Tweaks Industrial Average Roster, 3 High-Profile Names Gone
9/10/2013 4:17:00 PM - Seeking Alpha

Is It Time To Dump These 5 Dividend Growth Portfolio Stalwarts?
9/10/2013 8:03:00 AM - Seeking Alpha

Seems Like Old Times
9/6/2013 3:35:00 PM - Seeking Alpha

6 Reasons Advaxis May Be The Best Reward Vs. Risk In Healthcare
9/6/2013 2:47:00 PM - Seeking Alpha

Pfizer Looks Good Despite Disappointing Eliquis Sales
9/5/2013 4:18:00 PM - Seeking Alpha

Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
8/30/2013 3:47:00 PM - Seeking Alpha

Join With Merck For The Long Haul
8/29/2013 3:30:00 PM - Seeking Alpha

AstraZeneca Goes Back To The M&A Well Yet Again
8/26/2013 2:37:00 PM - Investopedia

What Does The FDA's Breakthrough Designation Mean For Investors?
8/26/2013 12:45:00 PM - Seeking Alpha

2 Pharma Stocks With More Than 25% YTD Returns To Consider
8/23/2013 3:46:00 PM - Seeking Alpha

Codexis Continues To Struggle With Little Relief In Sight
8/22/2013 10:14:00 AM - Seeking Alpha

Sanofi 17.7% July/August Upside Again Led Healthcare Dogs
8/22/2013 8:57:00 AM - Seeking Alpha

A Call For Merck To Cut R&D
8/21/2013 2:03:00 PM - Seeking Alpha

MannKind's Phase III Diabetes Drug Results Should Continue Its Upward Trend
8/20/2013 9:26:00 AM - Seeking Alpha

Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
8/12/2013 8:28:00 AM - Seeking Alpha

GTx Inc.: Reader Queries And A Few Random Thoughts
8/11/2013 9:13:00 PM - Seeking Alpha

Depomed: A Profit In Q2 And Stock Is Still Cheap Next To Comps
8/9/2013 3:34:00 PM - Seeking Alpha

Wedbush Expert Declares Money For Biotech Is Still Out There
8/9/2013 11:47:00 AM - Seeking Alpha

Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
8/5/2013 6:34:00 PM - Seeking Alpha